Potassium p-Aminobenzoate
- Atc Codes:D02BA01
- CAS Codes:138-84-1
- PHARMGKB ID:138-84-1
Table of contents
- Brand Names
- Chemistry
- Pharmacologic Category
- Mechanism of Action
- Therapeutic Use
- Pregnancy and Lactation Implications
- Contraindications
- Warnings and Precautions
- Adverse Reactions
- Genes that may be involved
- Drug Interactions
- Dosage
- Special Considerations
Brand Names
Europe
Austria: Potaba; Germany: Potaba; Greece: Potaba; Ireland: Potaba; UK: Potaba.
North America
USA: Potaba.
Drug combinations
Chemistry
Potassium p-Aminobenzoate: C~7~H~7~KNO~2~. Mw: 176.23. 4-Aminobenzoate potassium salt. CAS-138-84-1.
Pharmacologic Category
Vitamins; Vitamin B Complex. (ATC-Code: D02BA01).
Mechanism of action
Member of vitamin B complex family. May have antifibrotic effect due to increased oxygen uptake at tissue level.
Therapeutic use
Treatment of scleroderma, dermatomyositis, morphea, linear scleroderma, pemphigus, Peyronie’s disease.
Pregnancy and lactiation implications
Safety for use in pregnancy not established. Not recommended in breast-feeding (excretion in breast milk unknown).
Unlabeled use
Contraindications
Hypersensitivity to potassium p-aminobenzoate or any component of the formulation. Concurrent use of sulfonamides.
Warnings and precautions
Anorexia might occur. Nausea might occur. Use with caution in diabetes mellitus or history of hypoglycemia, and in renal impairment.